Literature DB >> 20460594

Four familial ALS pedigrees discordant for two SOD1 mutations: are all SOD1 mutations pathogenic?

Ansgar Felbecker1, William Camu, Paul N Valdmanis, Anne-Dorte Sperfeld, Stefan Waibel, Peter Steinbach, Guy A Rouleau, Albert C Ludolph, Peter M Andersen.   

Abstract

BACKGROUND: 153 mutations in the Cu/Zn superoxide dismutase (SOD1) gene have been claimed to be associated with amyotrophic lateral sclerosis (ALS) in familial and sporadic ALS in an autosomal dominant or autosomal recessive pattern with complete or reduced penetrance. The authors now report four ALS pedigrees from Finland, France, Germany and Sweden with either the D90A or E100K SOD1 mutations in some but not all affected members. After re-collecting DNA, the non-segregation of the SOD1 mutations with disease was confirmed by three independent laboratories using different PCR primers: while some of the affected patients carry SOD1 mutations, other affected family members have two wildtype/normal SOD1 genes. In addition, some unaffected members within the same families are carriers of SOD1 gene mutations. To exclude other known genetic causes, the authors ruled out mutations within the genes coding for VAPB, ANG, TDP43, FUS and DCTN1 in affected individuals in the four pedigrees.
CONCLUSIONS: The authors find that the D90A and E100K SOD1 gene mutations found in some patients are not the exclusive cause of ALS in these pedigrees. Whether this is also the case for the other 151 SOD1 mutations reported in ALS pedigrees is unknown. The findings have consequences for genetic testing in clinical practice when diagnosing ALS and for genetic counselling in ALS. Some SOD1 mutations may be part of an oligo- or epigentic pattern of inheritance. Such a pattern of inheritance may model other oligo- or polygenetic traits responsible for other forms of ALS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20460594     DOI: 10.1136/jnnp.2009.192310

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  21 in total

1.  A role for ubiquilin 2 mutations in neurodegeneration.

Authors:  Hussein Daoud; Guy A Rouleau
Journal:  Nat Rev Neurol       Date:  2011-10-11       Impact factor: 42.937

Review 2.  Familial Amyotrophic Lateral Sclerosis.

Authors:  Kevin Boylan
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

3.  The chaperone protein clusterin may serve as a cerebrospinal fluid biomarker for chronic spinal cord disorders in the dog.

Authors:  Intan N F Shafie; Mark McLaughlin; Richard Burchmore; Mary Ann A Lim; Paul Montague; Pamela E J Johnston; Jacques Penderis; Thomas J Anderson
Journal:  Cell Stress Chaperones       Date:  2013-08-29       Impact factor: 3.667

4.  Complexities of Genetic Counseling for ALS: A Case of Two Siblings with Discordant Genetic Test Results.

Authors:  Paola Mandich; Vittorio Mantero; Simonetta Verdiani; Fabio Gotta; Claudia Caponnetto; Emilia Bellone; Giovanna Ferrandes; Paola Origone
Journal:  J Genet Couns       Date:  2015-04-07       Impact factor: 2.537

Review 5.  Genetic causes of amyotrophic lateral sclerosis: new genetic analysis methodologies entailing new opportunities and challenges.

Authors:  Giuseppe Marangi; Bryan J Traynor
Journal:  Brain Res       Date:  2014-10-12       Impact factor: 3.252

Review 6.  [Genetics of amyotrophic lateral sclerosis].

Authors:  A Hübers; J H Weishaupt; A C Ludolph
Journal:  Nervenarzt       Date:  2013-10       Impact factor: 1.214

7.  ALS/FTD phenotype in two Sardinian families carrying both C9ORF72 and TARDBP mutations.

Authors:  Adriano Chiò; Gabriella Restagno; Maura Brunetti; Irene Ossola; Andrea Calvo; Antonio Canosa; Cristina Moglia; Gianluca Floris; Paolo Tacconi; Francesco Marrosu; Maria Giovanna Marrosu; Maria Rita Murru; Elisa Majounie; Alan E Renton; Yvegeniya Abramzon; Maura Pugliatti; Maria Alessandra Sotgiu; Bryan J Traynor; Giuseppe Borghero
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-05-01       Impact factor: 10.154

Review 8.  Presymptomatic ALS genetic counseling and testing: Experience and recommendations.

Authors:  Michael Benatar; Christine Stanislaw; Eliana Reyes; Sumaira Hussain; Anne Cooley; Maria Catalina Fernandez; Danielle D Dauphin; Sara-Claude Michon; Peter M Andersen; Joanne Wuu
Journal:  Neurology       Date:  2016-05-18       Impact factor: 9.910

9.  Extensive genetics of ALS: a population-based study in Italy.

Authors:  Adriano Chiò; Andrea Calvo; Letizia Mazzini; Roberto Cantello; Gabriele Mora; Cristina Moglia; Lucia Corrado; Sandra D'Alfonso; Elisa Majounie; Alan Renton; Fabrizio Pisano; Irene Ossola; Maura Brunetti; Bryan J Traynor; Gabriella Restagno
Journal:  Neurology       Date:  2012-10-24       Impact factor: 9.910

10.  Impact of presymptomatic genetic testing for familial amyotrophic lateral sclerosis.

Authors:  Joanna H Fanos; Susan Gronka; Joanne Wuu; Christine Stanislaw; Peter M Andersen; Michael Benatar
Journal:  Genet Med       Date:  2011-04       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.